Arialys Therapeutics develops precision medicines blocking pathogenic brain autoantibodies for autoimmune neuropsychiatric disease as a precision-medicine company for that disease.
Arialys Therapeutics Comparables - aVenture Research
How does Arialys Therapeutics compare with Aristea Therapeutics, Athos Therapeutics, and APRINOIA Therapeutics?
It depends on what you need. Arialys Therapeutics focuses on Therapeutics, serves Hospitals customers, is based in La Jolla, CA, US, and has raised $72.8M. Aristea Therapeutics focuses on Drugs, serves B2B and Enterprise customers, is based in San Diego, CA, US, and has raised $117.6M (last round: Series B). Athos Therapeutics focuses on Therapeutics, serves Enterprise customers, is based in Torrance, CA, US, and has raised $19.3M (last round: Series A). APRINOIA Therapeutics focuses on Diagnostic Tools and Therapies, serves Enterprise customers, is based in Cambridge, MA, US, and has raised $61.9M (last round: Series A).
